Showing results (551-560 of 603) with videos related to
Sort By:
Pageof 61
EJNMMI Research|June 5, 2013
Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancerJoseph A O'Donoghue, José G Guillem, Heiko Schöder, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PETJoseph A O'Donoghue, Peter M Smith-Jones, John L Humm, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastasesMilan Grkovski, Zachary A Kohutek, Heiko Schöder, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patientsAudrey Mauguen, Ravinder K Grewal, Finn Augensen, et al.Medical Physics|February 27, 2018
Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injectionAssen S Kirov, Louise M Fanchon, Daniel Seiter, et al.International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 22, 2015
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancerPat Zanzonico, Jorge A Carrasquillo, Neeta Pandit-Taskar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal TumorsNeeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal CancerJames E Han, Bill H Diplas, Ramesh Paudyal, et al.Pageof 61